Maxillofacial Plastic and Reconstructive Surgery

Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지

Gingival Squamous Carcinoma with Metastatic Lymph Node Involvement of Papillary Thyroid Carcinoma

  • Kim, Ju-Won (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Lee, Chang-Youn (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Oh, Seung-Min (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Yang, Byung-Eun (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Kim, Jwa-Young (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Song, Yun-Jung (Department of Conservative Dentistry, Hallym University College of Medicine) ;
  • Ahn, Kang-Min (Department of Oral and Maxillofacial Surgery, Seoul Asan Medical Center, College of Medicine, University of Ulsan) ;
  • Park, Joo-Yong (Oral Cancer Clinic, Research Institute and Hospital, National Cancer Center)
  • Received : 2012.05.05
  • Accepted : 2012.06.27
  • Published : 2012.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

The development of multiple primary tumors is a problem leading to the treatment of patients diagnosed with gingival squamous cell carcinoma (SCC). The occurrence of multiple primary cancers in patients with SCC of the head and neck is uncommon. Thyroid carcinomas have been found incidentally in the cervical lymph nodes after histopathologic examination. A 72-year-old male with SCC of the lower gingiva at the clinical stage T2N0M0 was treated with partial mandibulectomy and selective neck dissection. Histopathologic examination showed the foci of papillary thyroid carcinoma metastasis. The patient subsequently underwent total thyroidectomy. We report a case of papillary thyroid carcinoma associated with SCC of the oral gingiva along with a review of literatures.

Keywords

References

  1. Arbes SJ Jr, Olshan AF, Caplan DJ, Schoenbach VJ, Slade GD, Symons MJ. Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control 1999;10:513-23. https://doi.org/10.1023/A:1008911300100
  2. Shiboski CH, Shiboski SC, Silverman SJ. Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol 2000;28:249-56. https://doi.org/10.1034/j.1600-0528.2000.280402.x
  3. Coskun H, Erisen L, Tolunay S, Basut O, Onart S, Tezel I. Incidental association of thyroid carcinoma and squamous cell carcinoma of head and neck. Am J Otolaryngol 2002;23:228-32. https://doi.org/10.1053/ajot.2002.124541
  4. Larson JT, Adams GL, Fattah HA. Survival statistics for multiple primaries in head and neck cancer. Otolaryngol Head Neck Surg 1990;103:14-24. https://doi.org/10.1177/019459989010300103
  5. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75:1343-53. https://doi.org/10.1002/1097-0142(19950315)75:6<1343::AID-CNCR2820750617>3.0.CO;2-T
  6. Pitman KT, Johnson JT, Myers EN. Papillary thyroid carcinoma associated with squamous cell carcinoma of the head and neck: significance and treatment. Am J Otolaryngol 1996;17:190-6. https://doi.org/10.1016/S0196-0709(96)90059-9
  7. Schlumberger MJ, Filetti S, Hay ID. Nontoxic goiter and thyroid neoplasia. In: Larsen PR, editor. Williams textbook of endocrinology. 10th ed. Philadelphia: W.B Saunders; 2002.p.469-73.
  8. Shaha AR. Management of the neck in thyroid cancer. Otolaryngol Clin North Am 1998;31:823-31. https://doi.org/10.1016/S0030-6665(05)70090-6
  9. Huang SH, Wang PW, Huang YE, et al. Sequential follow- up of serum thyroglobulin and whole body scan in thyroid cancer patients without initial metastasis. Thyroid 2006;16:1273-8. https://doi.org/10.1089/thy.2006.16.1273
  10. Mazzaferri EL, Kloos RT. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions. Thyroid 2000;10:767-78. https://doi.org/10.1089/thy.2000.10.767
  11. National Comprehensive Cancer Network. Clinical practice guidelines in oncology (NCCN Guidelines)-Thyroid carcinoma, version 2. 2007 [2011 DEC 19]. Available from: http//www.nccn.org.
  12. Lee E, Lee SJ, Lee CR, et al. FDG-PET as a predictor of recurrence with 131I scan negative differentiated thyroid cancer: an evaluation compared with pathologic findings. J Korean Soc Endocrinol 1999;14:520-30.
  13. Benbassat CA, Mechlis-frish S, Guttmann H, Glaser B, Krausz Y. Current concepts in the follow-up of patients with differentiated thyroid cancer. IAMJ 2007;9:540-5.
  14. Goepfert H, Callender DL. Differentiated thyroid cancer-papillary and follicular carcinomas. Am J Otolaryngol 1994; 15:167-79. https://doi.org/10.1016/0196-0709(94)90001-9
  15. Godballe C, Asschenfeldt P, Sørensen JA, Sørensen MW, Jørgensen K. Papillary thyroid carcinoma: correlations between prognosis, age, and clinicopathological and histomorphological findings. Laryngoscope 1994;104:747-51.
  16. Mansi L, Moncayo R, Cuccurullo V, Dottorini ME, Rambaldi PF. Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer. Q J Nucl Med Mol Imaging 2004;48:82-95.